Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotype-guided Clopidogrel vs Ticagrelor in CAD patients undergoing PCI
NCT05516784Phase 4Completed
- Sponsor
- Universiti Sains Malaysia
- Start
- Sep 2019
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in coronary artery disease (CAD), sponsored by Universiti Sains Malaysia. Started Sep 2019; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT05516784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05516784.